Role of lymph node stroma and microenvironment in T cell tolerance. Issue 1 (19th September 2019)

• Record Type: Journal Article
• Authors: Saxena, Vikas; Li, Lushen; Paluskievicz, Christina; Kasinath, Vivek; Bean, Asher; Abdi, Reza; Jewell, Christopher M.; Bromberg, Jonathan S.
• Is Part Of: Immunological reviews. Volume 292:Issue 1(2019)
• Page Start: 9
• Page End: 23
• Publication Date: 2019-09-19
• Subjects: anergy -- autoimmune disease -- autoimmunity -- lymph nodes -- suppression -- T cell -- tolerance -- transplantation; Immunology -- Periodicals; Transplantation of organs, tissues, etc -- Periodicals; 616.079
• DOI: 10.1111/imr.12799
• Languages: English
• ISSNs: 0105-2896

Abstract

Abstract: Lymph nodes (LNs) are at the cross roads of immunity and tolerance. These tissues are compartmentalized into specialized niche areas by lymph node stromal cells (LN SCs). LN SCs shape the LN microenvironment and guide immunological cells into different zones through establishment of a CCL19 and CCL21 gradient. Following local immunological cues, LN SCs modulate activity to support immune cell priming, activation, and fate. This review will present our current understanding of LN SC subsets roles in regulating T cell tolerance. Three major types of LN SC subsets, namely fibroblastic reticular cells, lymphatic endothelial cells, and blood endothelial cells, are discussed. These subsets serve as scaffolds to support and regulate T cell homeostasis. They contribute to tolerance by presenting peripheral tissue antigens to both CD4 and CD8 T cells. The role of LN SCs in regulating T cell migration and tolerance induction is discussed. Looking forward, recent advances in bioengineered materials and approaches to leverage LN SCs to induce T cell tolerance are highlighted, as are current clinical practices that allow for manipulation of the LN microenvironment to induce tolerance. Increased understanding of LN architecture, how different LN SCs integrate immunological cues and shape immune responses, and approaches to induce T cell tolerance will help further combat autoimmune diseases and graft rejection.